Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Patients and physicians often both play a role when a patient’s treatment stalls. There are ways to prevent it.

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

The American Diabetes Association has released its annual update to ”Standards of Medical Care in Diabetes.” The document, published in Diabetes Care, includes all of the group's current clinical ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...